Not applicableNot Yet RecruitingNCT07828652
What this trial is testing
Real-world Treatment Outcomes and Safety of Neoadjuvant Pembrolizumab-containing Therapy in Patients With Triple-negative Breast Cancer: Korean Nationwide Multicenter Study (Pembro-Real World)
Who this might be right for
TNBC - Triple-Negative Breast Cancer
Yeon Hee Park 2,000